Marion Lee
Director/Miembro de la Junta en Deltex Medical Ltd. .
Perfil
Marion Ivy Lee is currently a Director at Deltex Medical Ltd.
Previously, Ms. Lee worked as a Sales Office Manager at Deltex Medical Group Plc from 1987 to 2015.
Cargos activos de Marion Lee
Empresas | Cargo | Inicio |
---|---|---|
Deltex Medical Ltd.
Deltex Medical Ltd. Medical DistributorsDistribution Services Part of Deltex Medical Group Plc, Deltex Medical Ltd. is a British manufacturer of fluid management devices, including the CardioQ-ODM and CardioQ-ODM+. The company is based in Chichester, UK. The British company provides a single platform, TrueVue™ with ODM+, measuring flow and pressure directly, which includes Oesophageal Doppler Monitoring, Pulse Pressure Waveform Analysis (PPWA) & High Definition Impedance Cardiography (HD-ICG) in a single unit. Enhanced Recovery has evolved, requiring individualised goal directed haemodynamic therapy, optimised through cardiac output monitoring. TrueVue™ Loops plots aortic blood flow velocity and pressure, on every heartbeat, displaying it graphically, providing a complete haemodynamic picture, in real-time. The company was founded in 1992. The CEO is Andrew Jonathan Mears. | Director/Miembro de la Junta | 01/05/2015 |
Antiguos cargos conocidos de Marion Lee.
Empresas | Cargo | Fin |
---|---|---|
DELTEX MEDICAL GROUP PLC | Oficial de Recursos Humanos | - |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
DELTEX MEDICAL GROUP PLC | Health Technology |
Empresas privadas | 1 |
---|---|
Deltex Medical Ltd.
Deltex Medical Ltd. Medical DistributorsDistribution Services Part of Deltex Medical Group Plc, Deltex Medical Ltd. is a British manufacturer of fluid management devices, including the CardioQ-ODM and CardioQ-ODM+. The company is based in Chichester, UK. The British company provides a single platform, TrueVue™ with ODM+, measuring flow and pressure directly, which includes Oesophageal Doppler Monitoring, Pulse Pressure Waveform Analysis (PPWA) & High Definition Impedance Cardiography (HD-ICG) in a single unit. Enhanced Recovery has evolved, requiring individualised goal directed haemodynamic therapy, optimised through cardiac output monitoring. TrueVue™ Loops plots aortic blood flow velocity and pressure, on every heartbeat, displaying it graphically, providing a complete haemodynamic picture, in real-time. The company was founded in 1992. The CEO is Andrew Jonathan Mears. | Distribution Services |
- Bolsa de valores
- Insiders
- Marion Lee